RNS Number:6514R
Phorm Inc
04 April 2008
Phorm, Inc. ('Phorm' or the 'Company')
Notification of Shareholding
Phorm Inc. (AIM: PHRM and PHRX) received notification on 2 April 2008 that on 27
March 2008 Majedie Investments Plc acquired an interest in the Company's shares
that resulted in Majedie Investments Plc holding a total of 539,555 common
shares representing approximately 3.9% of the issued share capital of the
Company.
As at 4 April 2008, the Company had 13,831,224 common shares with a nominal
value of US$0.001 per share with voting rights in issue, none of which are held
in treasury.
Enquiries:
Kent Ertugrul (Chairman & Chief Executive) +44 20 7638 9571
Lynne Millar (Chief Financial Officer)
Citigate Dewe Rogerson +44 20 7638 9571
Simon Rigby
Justin Griffiths
Canaccord Adams Limited +44 20 7050 6500
(Nominated Adviser)
Mark Williams
Andrew Chubb
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLGGGGDZDRGRZM
|